daratumumab in myeloma update: expanding indications
Published 5 years ago • 314 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
2:36
approaching a myeloma population becoming increasingly resistant to daratumumab
-
1:25
an update on the emn19 study: dara-vcd in multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
2:21
the role of daratumumab in the treatment of myeloma and insights into the maia trial
-
0:54
the experience of single-agent daratumumab for r/r myeloma in india
-
13:28
m-power ny | dr. saad usmani presents myeloma treatments: how do we treat myeloma?
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
0:52
the future of daratumumab in multiple myeloma
-
2:39
subcutaneous daratumumab: an update on the latest mm clinical trials
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:17
updates on the flt3 inhibitor ff-10101 for the treatment of r/r aml
-
1:06
evolving strategies for second- and third-line treatments in multiple myeloma
-
1:52
analyzing isatuximab in quadruplet combinations in transplant-ineligible multiple myeloma
-
1:10
latest developments in the treatment of emd in myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
2:19
improving global access to novel immunotherapies for patients with r/r dlbcl
-
1:10
how daratumumab will change the treatment of multiple myeloma